Opinion

Video

Promising Therapy Approaches for Advanced Friedreich Ataxia

A key opinion leader explores new and promising treatment approaches for managing advanced stages of Friedreich ataxia.

Video content above is prompted by the following:

  • In your opinion, what are the most promising emerging therapeutic avenues for managing advanced stages of FA, and how do you see them impacting clinical practice in the future?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
1 expert in this video
4 experts in this video
1 expert in this video
4 experts in this video
1 expert is featured in this series.
Dr Carrie Kitko
5 experts are featured in this series
Related Content
COVID-19 3D rendering | Image Credit: Production Perig - stock.adobe.com
July 8th 2025

Severe COVID-19 Linked to Higher Exacerbation, Mortality Risks in Patients With Bronchiectasis

Brooke McCormick
Patients with bronchiectasis face heightened risks of severe exacerbation and mortality after COVID-19 recovery, especially following severe cases.
managed care cast logo
December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick
On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
AJMC
July 8th 2025

Corticosteroid Premedication for Infliximab Remains Unnecessarily Common

Shirley Cohen-Mekelburg, MD, MS Jeffrey Gibbs, MD Beth Wallace, MD, MS Brooke Kenney, MPH Akbar K. Waljee, MD, MSc
Although use of corticosteroid premedication prior to infliximab infusions is declining, it remains unnecessarily high despite limited benefit and the risk of serious adverse events from corticosteroids.
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
Cases Show How Epcoritamab Revived CAR T Cells After Relapse in DLBCL
July 7th 2025

Cases Show How Epcoritamab Revived CAR T Cells After Relapse in DLBCL

Mary Caffrey
man with mulitple sclerosis and walker | Image credit: chartphoto - stock.adobe.com
July 7th 2025

The Rise of Precision Monoclonal Antibodies in Treating MS

Skylar Jeremias
Advancements in B-cell therapies, including anti-CD20 and anti-CD19 monoclonal antibodies, enhance treatment efficacy and safety for multiple sclerosis and autoimmune diseases.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo